Richard Croker
Pharmaceutical adviser
Richard is the pharmaceutical adviser for OpenPrescribing at the Bennett Institute. He has worked as a pharmaceutical adviser for the NHS for 15 years, and is currently also the Head of Medicines Optimisation for Northern, Eastern and Western Devon CCG. He has a BSc in Pharmacy from the University of Portsmouth, and an MSc in Health Informatics from Swansea University, where his dissertation centred on the validity of prescribing denominators. He also spends his time applying medicines optimisation principles to improving pathology services in the NHS.
Papers by Richard Croker
Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care
(PRE-PRINT) OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?
Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care
Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care.
Is Use of Homeopathy Associated With Poor Prescribing in English Primary Care? A Cross-Sectional Study
Optimising laboratory monitoring of chronic conditions in primary care: a quality improvement framework
Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data
Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care
Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study
Six months on – NHS England needs to focus on dissemination, implementation and audit of its Low-Priority Initiative
Detecting Change in Comparison to Peers in NHS Prescribing Data: a Novel Application of Cumulative Sum Methodology
Pregabalin: what the patent litigation means for doctors and drug companies
The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care
Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care
Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study
New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study
Blogs by Richard Croker
Additional Functions on Analyse page - multi-level searching and STP/NHS England regions
How can we improve the management of necessary changes in clinical practice?
Two new measures on OpenPrescribing — Herbal medicines and Freestyle Libre
